Literature DB >> 17251615

Management of patients with implantable cardioverter defibrillators at emergency departments.

Chung-Pin Liu1, Yi-Lwun Ho, Yen-Hung Lin, Yen-Bin Liu, Wei-Tien Chang, Chien-Hua Huang, Wen-Jone Chen.   

Abstract

BACKGROUND: With rapid improvements in technology and accumulation of clinical evidence, the implantable cardioverter defibrillator (ICD) has become a standard treatment for either primary or secondary prevention of sudden cardiac death. However, no analysis based on the perspective of emergency department has been reported, and managing patients with ICD remains a challenge to the emergency department doctors.
METHODS: This study reviewed the emergency department visits of patients who received ICD implantation in a single university hospital from 1995 to 2004. The baseline demographic and laboratory data were compared between groups with the non-parametric method of the Mann-Whitney U test for continuous data and the chi2 test for categorical data; p<0.05 was considered significant.
RESULTS: 81 patients (56 men and 25 women) were included in this study. 43% of patients had at least one emergency department visit during the follow-up period, and a total of 86 emergency department visits were recorded. The most frequent aetiology of emergency department visits was ICD discharge (37 episodes; 43.1%) and the most frequent presenting symptom was electric shock sensation (25 episodes; 29.1%). Only 11 (12.8%) emergency department visits were because of non-cardiac aetiologies. Patients with emergency department visits had significant lower left ventricular ejection fraction (mean (SD) 41.5 (19.8) v 55.2 (18.4) ejection fraction units; p = 0.005) and more use of warfarin (8.6% v 0%; p<0.05). Although most emergency department visits were device or arrhythmia related, the acute coronary syndrome and congestive heart failure still accounted for 27.9% of hospital returns in combination.
CONCLUSIONS: Defibrillator discharge, acute coronary syndrome and heart failure constitute most aetiologies of emergency department visits of patients with ICD. The risk factors include lower left ventricular ejection fraction and use of warfarin.

Entities:  

Mesh:

Year:  2007        PMID: 17251615      PMCID: PMC2658183          DOI: 10.1136/emj.2006.037788

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  18 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.

Authors:  R N Hauer ; E Aliot; M Block; A Capucci; B Lüderitz; M Santini; P E Vardas
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

3.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

Review 4.  Implantable cardioverter-defibrillators.

Authors:  John P DiMarco
Journal:  N Engl J Med       Date:  2003-11-06       Impact factor: 91.245

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study.

Authors:  T Korte; W Jung; G Ostermann; C Wolpert; S Spehl; B Esmailzadeh; B Lüderitz
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

7.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

Review 8.  An update on implantable cardioverter-defibrillator guidelines.

Authors:  Andrew E Epstein
Journal:  Curr Opin Cardiol       Date:  2004-01       Impact factor: 2.161

9.  Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan.

Authors:  Jyh-Ming Juang; Shoei K Stephen Huang; Chia-Ti Tsai; Fu-Tien Chiang; Jiunn-Lee Lin; Ling-Ping Lai; Chun-Chieh Wang; Chi-Tai Kuo; Kwo-Chang Ueng; Chi-Woon Kong; Wen-Chin Ko; Meng-Huan Lei; Hsuan-Ming Tsao
Journal:  Cardiology       Date:  2003       Impact factor: 1.869

10.  Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.

Authors:  Chia-Ti Tsai; Shoei K Stephen Huang; Jiunn-Lee Lin; Ling-Ping Lai
Journal:  Pacing Clin Electrophysiol       Date:  2003-11       Impact factor: 1.976

View more
  2 in total

1.  Inappropriately Firing Defibrillator: A Simulation Case for Emergency Medicine Residents.

Authors:  Rachel Lauren Thorpe; Namit Rohant; Michael Cryer; Christopher Gainey
Journal:  MedEdPORTAL       Date:  2019-02-27

2.  An Atypical Presentation of Twiddler's Syndrome: A Case Report.

Authors:  Hugo Liano Calavia; Menna Awadalla; Syed Alishan Nasir; Jean Hammel
Journal:  Cureus       Date:  2022-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.